Successful use of Tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis

Author(s):
Magro Checa, C.; Casado, A.N.P.; Borrego-Garcia, E.; Raya-Alvarez, E.; Rosales-Alexander, J.L.; Salvatierra, J.; Caballero-Morales, T.; Gomez-Morales, M.
Published
2011
Publication type
Article / Letter to editor
Secondary amyloidosisnephrotic syndrometuberculosistocilizumabbiologics
Date issued
2011-12-31
Language
English
Is part of
Amyloid (2011), Vol. 18, no. 4, p. 235-239
hdl
1887/87677
doi
10.3109/13506129.2011.613962